Table 5 Susceptibilty of KPC-K.pneumoniae blood isolates determined by broth microdilution according to 2019 EUCAST breakpoints (38)
Period 1 | Period 2 | |||
|---|---|---|---|---|
N of blood isolates | 18 | 16 | ||
MIC range (mg/L) | N(%) of susceptible isolates | MIC range (mg/L) | N (%) of susceptible isolates | |
Colistin | 0.25–32 | 11 (67) | 0.5–4 | 14 (87.5) |
Tigecycline | 2–8 | 0 | 0.5–2 | 8 (50) |
Gentamicin | 1.5– >256 | 8 (44) | 1– >8 | 8 (50) |
Ceftazidime-avibactam | 0.5/4–8/4 | 18 (100) | 0.5/4–8/4 | 16 (100) |
Meropenem | > 32 | 0 | > 32 | 0 |
Imipenem | > 32 | 0 | > 32 | 0 |
Ertapenem | > 32 | 0 | > 32 | 0 |